©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

Illness46XY - gonadal dysgenesis, differential diagnosis

Summary

Short information

A comprehensive panel containing altogether 23 guideline-curated genes for the thorough analysis of genetic causes for 46XY-gonadal dysgenesis

ID
GP8127
Number of genes
11 Accredited laboratory test
Examined sequence length
20,3 kb (Core-/Core-canditate-Genes)
21,9 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

{Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
DHH1191NM_021044.4AR
DHX373474NM_032656.4AD
DMRT11122NM_021951.3AD
GATA41329NM_002052.5AD
MAP3K14539NM_005921.2AD
NR5A11386NM_004959.5AD
SOX91530NM_000346.4AD
SRY615NM_003140.3YL
WT11569NM_024426.6AD, SMu
ZFPM23456NM_012082.4AD
CBX21599NM_005189.3AR

Informations about the disease

Clinical Comment

Pure 46XY gonadal dysgenesis (GD) presents as phenotypically female, possibly with high stature, bilateral streak gonads, delayed puberty, amenorrhoea and small or normal Müller structures. If 46XY GD was not diagnosed at birth, delayed puberty and primary amenorrhoea are noticeable in adolescence. Patients rarely have tumour masses in the abdominal/pelvic area, but then often a gonadoblastoma. Occasionally 46XY GD may be linked to other syndromes. Patients with partial or mixed 46XY GD typically show different degrees of masculinisation of the external and internal genitalia at birth, depending on the proportion of testicular tissue, usually with female external genitalia and a certain degree of virilisation. Main criteria for the diagnosis of 46XY GD are appearance and histology of the gonads. As the risk of gonadoblastoma is increased in these patients, the exact diagnosis is made after prophylactic or therapeutic gonadectomy. Sequence analysis of the SRY and NR5A1 genes reveals mutations only in up to 30% of 46XY GD. Examination of other genes increases the percentage in differential diagnosis, especially examination of the MAP3K1 gene. All inheritance patterns are observed. An inconspicuous genetic finding does not mean a reliable exclusion of the clinical suspected diagnosis.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK539886/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182188/

 

Synonyms
  • Alias: 46,XY pure gonadal dysgenesis
  • Alias: 46XY intersex
  • Alias: 46XY sex reversal
  • Alias: Pseudohermaphroditism
  • Alias: Swyer syndrome
  • Allelic: 46XX sex reversal 1 (SRY)
  • Allelic: 46XX sex reversal 4 (NR5A1)
  • Allelic: Acampomelic campomelic dysplasia (SOX9)
  • Allelic: Adrenal hypoplasia, congenital (NR0B1)
  • Allelic: Adrenocortical insufficiency (NR5A1)
  • Allelic: Alpha-thalassemia/mental retardation syndrome (ATRX)
  • Allelic: Apert syndrome (FGFR2)
  • Allelic: Atrial septal defect 2 (GATA4)
  • Allelic: Atrioventricular septal defect 4 (GATA4)
  • Allelic: Beare-Stevenson cutis gyrata syndrome (FGFR2)
  • Allelic: Bent bone dysplasia syndrome (FGFR2)
  • Allelic: Campomelic dysplasia (SOX9)
  • Allelic: Craniofacial-skeletal-dermatologic dysplasia (FGFR2)
  • Allelic: Craniosynostosis, nonspecific (FGFR2)
  • Allelic: Crouzon syndrome (FGFR2)
  • Allelic: Developmental + epileptic encephalopathy 1 (ARX)
  • Allelic: Developmental + epileptic encephalopathy 28 (WWOX)
  • Allelic: Diaphragmatic hernia 3 (ZFPM2)
  • Allelic: Hydranencephaly with abnormal genitalia (ARX)
  • Allelic: Hypospadias 2, XL (MAMLD1)
  • Allelic: Intellectual developmental disorder, X 29 (ARX)
  • Allelic: Jackson-Weiss syndrome (FGFR2)
  • Allelic: LADD syndrome (FGFR2)
  • Allelic: Lissencephaly, XL 2 (ARX)
  • Allelic: Mental retardation-hypotonic facies syndrome, XL (ATRX)
  • Allelic: Mullerian aplasia + hyperandrogenism (WNT4)
  • Allelic: Nephrotic syndrome, type 4 (WT1)
  • Allelic: Neurodevelopm. disorder, brain anomalies with/-out vertebral/cardiac anomalies (DHX37)
  • Allelic: Ovarian dysgenesis 8 (ESR2)
  • Allelic: Partington syndrome (ARX)
  • Allelic: Pfeiffer syndrome (FGFR2)
  • Allelic: Premature ovarian failure 7 (NR5A1)
  • Allelic: SERKAL: 46,XX SEx Reversal with dysgenesis of Kidney, Adrenals + Lungs syndrome (WNT4)
  • Allelic: Saethre-Chotzen syndrome (FGFR2)
  • Allelic: Scaphocephaly and Axenfeld-Rieger anomaly (FGFR2)
  • Allelic: Scaphocephaly, maxillary retrusion, and mental retardation (FGFR2)
  • Allelic: Spermatogenic failure 8 (NR5A1)
  • Allelic: Spinocerebellar ataxia, AR 12 (WWOX)
  • Allelic: Tetralogy of Fallot (GATA4)
  • Allelic: Tetralogy of Fallot (ZFPM2)
  • Allelic: Ventricular septal defect 1 (GATA4)
  • Allelic: Wilms tumor, type 1 (WT1)
  • 46XY disorder of sex development [MONDO:0020040] (ESR2)
  • 46XY gonadal dysgenesis [guidelines] (STARD8)
  • 46XY gonadal dysgenesis [guidelines] (ZNRF3)
  • 46XY gonadal dysgenesis with minifascicular neuropathy (DHH)
  • 46XY sex reversal 1 (SRY)
  • 46XY sex reversal 11, testicular regression syndrome (DHX37)
  • 46XY sex reversal 2, dosage-sensitive (NR0B1)
  • 46XY sex reversal 3 (NR5A1)
  • 46XY sex reversal 5 (CBX2)
  • 46XY sex reversal 6 (MAP3K1)
  • 46XY sex reversal 7 (DHH)
  • 46XY sex reversal 9 (ZFPM2)
  • Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis (FGFR2)
  • CAKUTHED: Cong. Anom. Kidney/Urinary Tract syn. +/- Hear loss, abn. Ears or Development delay (PBX1)
  • Campomelic dysplasia with autosomal sex reversal (SOX9)
  • Denys-Drash syndrome (WT1)
  • Frasier syndrome (WT1)
  • Gender Assignment Gene Panel (MAMLD1)
  • Gonadal dysgenesis [Lit.], Gender Assignment Gene Panel (DMRT1)
  • Meacham syndrome (WT1)
  • Nivelon-Nivelon-Mabille [Chondrodysplasia-pseudohermaphroditism] syndrome (HHAT)
  • Proud syndrome, Corpus callosum, agenesis, with abnormal genitalia (ARX)
  • Schizencephaly (EMX2)
  • Skeletal anomalies, learning difficulty [guidelines] (SOX8)
  • Sudden infant death with dysgenesis of the testes syndrome (TSPYL1)
  • Testicular anomalies with/-out congenital heart disease (GATA4)
Heredity, heredity patterns etc.
  • AD
  • AR
  • SMu
  • YL
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde